Daniel Orbach Selected Research

Malignant mesenchymal tumor

1/2020	Is surveillance imaging in pediatric patients treated for localized rhabdomyosarcoma useful? The European experience.
1/2018	Prognostic relevance of early radiologic response to induction chemotherapy in pediatric rhabdomyosarcoma: A report from the International Society of Pediatric Oncology Malignant Mesenchymal Tumor 95 study.
1/2017	Nonparameningeal head and neck rhabdomyosarcoma in children and adolescents: Lessons from the consecutive International Society of Pediatric Oncology Malignant Mesenchymal Tumor studies.
9/2012	Local therapy is critical in localised pelvic rhabdomyosarcoma: experience of the International Society of Pediatric Oncology Malignant Mesenchymal Tumor (SIOP-MMT) committee.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Daniel Orbach Research Topics

Disease

68	Neoplasms (Cancer) 11/2022 - 12/2003
25	Rhabdomyosarcoma 01/2022 - 12/2003
19	Sarcoma (Soft Tissue Sarcoma) 01/2022 - 09/2006
4	Malignant mesenchymal tumor 01/2020 - 09/2012
3	Aggressive Fibromatosis (Desmoid) 01/2021 - 12/2017
3	Fibroma (Fibromatosis) 01/2021 - 12/2017
3	Rupture 01/2020 - 06/2015
3	Neutropenia 11/2019 - 02/2007
3	Thrombocytopenia (Thrombopenia) 11/2019 - 02/2007
3	Nasopharyngeal Carcinoma 06/2019 - 04/2008
2	Brain Neoplasms (Brain Tumor) 01/2022 - 09/2006
2	Neoplasm Metastasis (Metastasis) 05/2021 - 10/2014
2	Myofibromatosis 01/2021 - 07/2012
2	Seizures (Absence Seizure) 01/2021 - 01/2018
2	Mesothelioma 11/2020 - 04/2018
2	Paraganglioma (Paragangliomas) 05/2020 - 10/2016
2	Teratoma (Teratoid Tumor) 01/2020 - 04/2013
2	Fibrosarcoma 01/2020 - 01/2010
2	Infections 11/2019 - 01/2018
2	Pain (Aches) 11/2019 - 02/2011
2	Neurofibrosarcoma (MPNST) 10/2019 - 03/2011
2	Wilms Tumor (Wilm's Tumor) 01/2019 - 01/2019
2	Embryonal Rhabdomyosarcoma 12/2017 - 05/2010
2	Synovial Sarcoma (Synovioma) 01/2017 - 12/2011
2	Neuroblastoma 10/2016 - 01/2006
2	Osteosarcoma (Osteogenic Sarcoma) 11/2009 - 08/2007
1	Hematologic Neoplasms (Hematological Malignancy) 06/2022
1	Chickenpox 03/2022
1	Hypothyroidism 01/2022
1	Thyroid Nodule (Nodule, Thyroid) 01/2022
1	Malignant Pleural Effusion 01/2021
1	Sex Cord-Gonadal Stromal Tumors (Sex Cord-Stromal Tumor) 01/2021
1	Disease Progression 01/2021
1	Malignant Mesothelioma 11/2020
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 10/2020
1	Residual Neoplasm 01/2020
1	Second Primary Neoplasms (Neoplasms, Second) 01/2020
1	Septic Shock (Toxic Shock Syndrome) 01/2018

Drug/Important Bio-Agent (IBA)

6	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 12/2003
5	Ifosfamide FDA LinkGeneric 01/2022 - 12/2003
5	Biological ProductsIBA 08/2021 - 05/2010
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022 - 12/2003
4	2-methylcyclopentadienyl manganese tricarbonyl (MMT)IBA 01/2020 - 12/2011
3	Bevacizumab (Avastin)FDA Link 11/2021 - 01/2017
3	PlatinumIBA 06/2019 - 04/2013
3	Cisplatin (Platino)FDA LinkGeneric 02/2016 - 12/2003
2	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2021
2	Etoposide (VP 16)FDA LinkGeneric 01/2022 - 12/2003
2	Vincristine (Oncovin)FDA LinkGeneric 01/2022 - 12/2003
2	Anaplastic Lymphoma KinaseIBA 01/2022 - 01/2016
2	Fetal Proteins (Fetoprotein)IBA 01/2021 - 11/2014
2	Vinblastine (Vinblastine Sulfate)FDA Link 01/2021 - 07/2012
2	Methotrexate (Mexate)FDA LinkGeneric 01/2021 - 07/2012
2	Vinorelbine (Navelbine)FDA LinkGeneric 11/2019 - 10/2012
2	Vasopressins (Vasopressin)IBA 11/2019 - 01/2014
2	CatecholaminesIBA 10/2016 - 10/2014
2	SaltsIBA 01/2014 - 04/2013
2	Alkylating AgentsIBA 01/2010 - 12/2003
1	Acyclovir (Aciclovir)FDA LinkGeneric 03/2022
1	Adrenocorticotropic Hormone (ACTH)FDA Link 01/2022
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2022
1	Immune Checkpoint InhibitorsIBA 08/2021
1	Tyrosine Kinase InhibitorsIBA 01/2021
1	Imatinib Mesylate (Gleevec)FDA Link 01/2021
1	DesminIBA 01/2021
1	MyogeninIBA 01/2021
1	Pemetrexed (MTA)FDA Link 11/2020
1	AsbestosIBA 11/2020
1	Succinate Dehydrogenase (Fumarate Reductase)IBA 05/2020
1	TropomyosinIBA 01/2020
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2020
1	Phosphotransferases (Kinase)IBA 01/2020
1	CI 22IBA 01/2020
1	MicroRNAs (MicroRNA)IBA 12/2019
1	Hydroxyurea (Hydrea)FDA LinkGeneric 01/2019
1	penicillamine-glutathione mixed disulfideIBA 01/2019
1	Pharmaceutical PreparationsIBA 01/2018

Therapy/Procedure

50	Drug Therapy (Chemotherapy) 01/2022 - 12/2003
30	Radiotherapy 11/2022 - 12/2003
27	Therapeutics 11/2022 - 12/2003
8	Neoadjuvant Therapy 01/2022 - 11/2015
6	Adjuvant Chemotherapy 01/2021 - 11/2008
5	Combination Drug Therapy (Combination Chemotherapy) 12/2014 - 12/2003
4	Induction Chemotherapy 01/2021 - 12/2014
3	Immunotherapy 08/2021 - 01/2018
3	Cytoreduction Surgical Procedures 11/2020 - 08/2010
3	Aftercare (After-Treatment) 07/2017 - 10/2006
2	Terminal Care (Care, Terminal) 06/2022 - 03/2017
2	Palliative Care (Palliative Therapy) 01/2021 - 03/2017
2	Adjuvant Radiotherapy 10/2019 - 07/2011
2	Hyperthermic Intraperitoneal Chemotherapy 04/2018 - 08/2010
1	Pituitary Irradiation 01/2022
1	Brachytherapy 01/2022
1	Vascular Access Devices (Arterial Line) 01/2021
1	Maintenance Chemotherapy 11/2019
1	Complementary Therapies (Alternative Medicine) 03/2019
1	Length of Stay 01/2019
1	Nephrectomy 01/2019
1	Drug Tapering 01/2019
1	Operative Time 01/2019